Stockreport

UPDATE 3-Lilly's cancer therapy Lartruvo fails study, shares drop [Reuters]

LOXO ONCOLOGY  (LOXO) 
Last loxo oncology earnings: 11/8 06:45 am Check Earnings Report
US:NASDAQ Investor Relations: ir.loxooncology.com
PDF Lilly's cancer therapy Lartruvo fails study, shares drop (Reuters) - Eli Lilly and Co said on Friday its cancer treatment Lartruvo, approved on an accelerated basis in 2 [Read more]